{"id":10325,"date":"2026-05-17T05:22:24","date_gmt":"2026-05-16T22:22:24","guid":{"rendered":"https:\/\/drsoaraweeurology.com\/?page_id=10325"},"modified":"2026-09-08T16:30:02","modified_gmt":"2026-09-08T09:30:02","slug":"%e7%a0%94%e7%a9%b6","status":"publish","type":"page","link":"https:\/\/drsoaraweeurology.com\/ja\/research\/","title":{"rendered":"\u7814\u7a76\u30fb\u5b66\u8853\u8ca2\u732e"},"content":{"rendered":"\n
\n

Research & Academic Contributions<\/h2>\n\n\n\n

Dr. Soarawee Weerasopone is currently a Research Scholar & Clinical Observer at the Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA \u2014 contributing to peer-reviewed research in Men’s Health and Sexual Medicine under the mentorship of Professor Mohit Khera, former President of the Sexual Medicine Society of North America (SMSNA).<\/p>\n\n\n\n

Dr. Soarawee’s clinical practice is in Thailand, at Bangkok Hospital Headquarters and Samitivej Sriracha Hospital. His formal specialist training is Thai board certification in urological surgery (2016) and two clinical fellowships at Chang Gung Memorial Hospital, Taiwan (2019) \u2014 Andrology, at the Kaohsiung branch under Professor Po-Hui Chiang, and Robotic Surgery with Minimally Invasive Urology, at the Linkou branch.<\/em><\/p>\n\n\n\n

<\/div>\n\n\n\n
\"Dr.
Dr. Soarawee with Professor Mohit Khera \u2014 Scott Department of Urology, Baylor College of Medicine<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n\n\n\n
\n

Peer-Reviewed Publications<\/h2>\n\n\n\n

Research published, or accepted for publication, in indexed academic journals. Author role is stated on every entry.<\/p>\n\n\n\n

<\/div>\n\n\n\n

As First Author<\/h3>\n\n\n\n
<\/div>\n\n\n\n
\n

\ud83d\udcd6 PUBLISHED ARTICLE \u00b7 JOURNAL OF SEXUAL MEDICINE \u00b7 2026<\/p>\n\n\n\n

Clinical drivers and outcomes of first-presentation erectile dysfunction in octogenarians: a 15-year retrospective cohort study at a tertiary center<\/h4>\n\n\n\n

Authors:<\/strong> Weerasopone S<\/strong>, Coady PJ, Walia A, Hernandez BS, Khera M<\/p>\n\n\n\n

Citation:<\/strong> The Journal of Sexual Medicine<\/em>, Volume 23, Issue 9, September 2026, qdag273 \u00b7 Published 7 September 2026<\/p>\n\n\n\n

Affiliations:<\/strong> Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA \u00b7 Bangkok Hospital Headquarters, Bangkok, Thailand<\/p>\n\n\n\n

Role:<\/strong> First Author<\/p>\n\n\n\n

Scope:<\/strong> A 15-year retrospective cohort of men who first presented with erectile dysfunction in their eighties, examining the clinical drivers of that first presentation and how treatment was escalated. The related work was selected as a Sushil Lacy Manuscript Finalist at the 2026 South Central Section AUA meeting.<\/p>\n\n\n\n

\n
Read on the Publisher Site \u2192<\/a><\/div>\n<\/div>\n\n\n\n

DOI:<\/strong> 10.1093\/jsxmed\/qdag273 \u00b7 Subscription access via the publisher.<\/em><\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n

\ud83d\udcd6 ACCEPTED \u00b7 SEXUAL MEDICINE \u00b7 OPEN ACCESS \u00b7 2026<\/p>\n\n\n\n

The Impact of Obesity and Obstructive Sleep Apnea on Vascular Hemodynamics in Men Under 40: A 15-Year Retrospective Cohort Study<\/h4>\n\n\n\n

Journal:<\/strong> Sexual Medicine (Oxford University Press) \u00b7 Accepted 1 September 2026<\/p>\n\n\n\n

Affiliations:<\/strong> Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA \u00b7 Bangkok Hospital Headquarters, Bangkok, Thailand<\/p>\n\n\n\n

Role:<\/strong> First Author<\/p>\n\n\n\n

Scope:<\/strong> A 15-year retrospective cohort of men under 40 undergoing penile duplex ultrasound, examining obesity and obstructive sleep apnea against measured penile vascular function.<\/p>\n\n\n\n

DOI:<\/strong> 10.1093\/sexmed\/qfag086 \u00b7 Accepted and in production. Findings are not summarised here ahead of publication; the DOI is pre-registered by the publisher and redirects to the article once it is released.<\/em><\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n

\ud83d\udcd6 PUBLISHED ARTICLE \u00b7 2023<\/p>\n\n\n\n

Validation of the Thai Version of the Incontinence Impact Questionnaire (IIQ-7) and the Urogenital Distress Inventory (UDI-6)<\/h4>\n\n\n\n

Authors:<\/strong> Weerasopone S, Santingamkul A<\/p>\n\n\n\n

Journal:<\/strong> Chulalongkorn Medical Journal (Chula Med J), Vol. 60, No. 4 \u00b7 Published August 25, 2023<\/p>\n\n\n\n

Affiliation:<\/strong> Division of Urology, Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand<\/p>\n\n\n\n

Role:<\/strong> First Author<\/p>\n\n\n\n

Summary:<\/strong> This validation study confirmed that the Thai IIQ-7 and UDI-6 are reliable, valid, and consistent instruments for assessing symptom severity and the impact on quality of life in Thai patients with urinary incontinence \u2014 making these clinically essential tools available for the Thai-speaking population.<\/p>\n\n\n\n

\n
Read Full Article \u2192<\/a><\/div>\n\n\n\n
View on ResearchGate<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

As Co-Author<\/h3>\n\n\n\n
<\/div>\n\n\n\n
\n

\ud83d\udcd6 PUBLISHED ARTICLE \u00b7 JOURNAL OF SEXUAL MEDICINE \u00b7 2026<\/p>\n\n\n\n

Testosterone replacement therapy in male octogenarians: clinical outcomes and adverse event rates<\/h4>\n\n\n\n

Authors:<\/strong> Coady PJ, Walia A, Oppenheimer A, Hernandez BS, Chidananda R, Hinojosa-Gonzalez DE, Weerasopone S<\/strong>, Kohn T, Khera M<\/p>\n\n\n\n

Citation:<\/strong> The Journal of Sexual Medicine<\/em>, Volume 23, Issue 9, September 2026, qdag258 \u00b7 Published 22 August 2026<\/p>\n\n\n\n

Affiliation:<\/strong> Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA<\/p>\n\n\n\n

Role:<\/strong> Co-Author<\/p>\n\n\n\n

What the study asked:<\/strong> Men aged 80 and over are almost entirely absent from the trials that guide testosterone prescribing \u2014 both TRAVERSE and the T-Trials excluded or did not report separately on them, and both excluded men with a history of prostate cancer. This single-centre retrospective cohort followed 46 hypogonadal men aged 80 or older through 36 months of treatment.<\/p>\n\n\n\n

What it found:<\/strong> Monitoring findings were reassuring. No patient reached a haematocrit of 54% or above<\/strong>, the threshold that usually forces treatment to change, and there was no biopsy-confirmed prostate cancer recurrence<\/strong> \u2014 notable because 39% of the cohort had a prostate cancer history. Blood pressure changed modestly overall (median +3 mmHg systolic), though six men rose by at least 20 mmHg, which is why blood pressure and haematocrit monitoring remain necessary rather than optional in this age group. All-cause mortality was 8.7% and 28.3% stopped treatment over the three years.<\/p>\n\n\n\n

What it cannot show:<\/strong> The authors are explicit about the limits. There was no untreated comparison group<\/strong>, so the cardiovascular and thromboembolic events cannot be attributed to the treatment rather than to a medically complex population \u2014 60.9% had hypertension and 30.4% coronary artery disease at baseline. The sample is small, the setting is a single centre, and the retrospective design means events treated elsewhere may have been missed. The paper calls for larger prospective studies with age-matched controls.<\/p>\n\n\n\n

\n
Read on the Publisher Site \u2192<\/a><\/div>\n<\/div>\n\n\n\n

DOI:<\/strong> 10.1093\/jsxmed\/qdag258 \u00b7 Subscription access via the publisher. Approved by IRB H-49807.<\/em><\/p>\n\n\n\n

Declared interests:<\/strong> The senior author declares consulting relationships with several pharmaceutical and device companies, as published with the article. Dr. Soarawee and the remaining authors declared no competing interests.<\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n

A complete and independently maintained publication record is available on ORCID (0009-0004-8387-3559)<\/a>. Findings described on this page summarise published research in groups of patients; they are not advice about any individual\u2019s treatment.<\/em><\/p>\n<\/div>\n\n\n\n

\n\n\n\n
\n

Conference Acceptances 2026<\/h2>\n\n\n\n

\ud83d\udccd 105th Annual Meeting, South Central Section AUA \u00b7 Tucson, Arizona, USA \u00b7 September 9\u201312, 2026<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n

\u2b50 SUSHIL LACY MANUSCRIPT FINALIST<\/p>\n\n\n\n

Clinical Drivers and Outcomes of First Presentation Erectile Dysfunction in Octogenarians: A 15-Year Retrospective Cohort Study at a Tertiary Center<\/h3>\n\n\n\n

Authors:<\/strong> Soarawee Weerasopone, Peyton Coady, Arnaav Walia, Beatriz S Hernandez, Mohit Khera<\/p>\n\n\n\n

Affiliations:<\/strong> Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA \u00b7 Bangkok Hospital Headquarters, Bangkok, Thailand<\/p>\n\n\n\n

Session:<\/strong> Sushil Lacy Manuscript Finalist Session (Finalist #5)<\/p>\n\n\n\n

Presentation:<\/strong> Thursday, September 10, 2026 \u00b7 1:40 PM<\/p>\n\n\n\n

Role:<\/strong> First Author & Presenter<\/p>\n\n\n\n

Status:<\/strong> \u2705 Accepted \u2014 awaiting presentation. The related manuscript is now published<\/strong> in The Journal of Sexual Medicine<\/em>, 23(9), qdag273, 7 September 2026 \u2014 see the Peer-Reviewed Publications section above for the full citation.<\/p>\n\n\n\n

Published Article:<\/strong> 10.1093\/jsxmed\/qdag273 \u2197<\/a><\/p>\n\n\n\n

Official Listing:<\/strong> Verified in the SCS AUA 2026 Official Program Schedule \u2197<\/a><\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n

\ud83d\udcca PODIUM PRESENTATION<\/p>\n\n\n\n

The Impact of Obesity and Obstructive Sleep Apnea on Vascular Hemodynamics in Men Under 40: A 15-Year Retrospective Cohort Study<\/h3>\n\n\n\n

Authors:<\/strong> Soarawee Weerasopone, Peyton Coady, Arnaav Walia, Beatriz S Hernandez, Mohit Khera<\/p>\n\n\n\n

Affiliations:<\/strong> Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA \u00b7 Bangkok Hospital Headquarters, Bangkok, Thailand<\/p>\n\n\n\n

Session:<\/strong> Male & Female Sexual & Reproductive Podium Session (Podium #2)<\/p>\n\n\n\n

Presentation:<\/strong> Thursday, September 10, 2026 \u00b7 11:07 AM<\/p>\n\n\n\n

Role:<\/strong> First Author & Presenter<\/p>\n\n\n\n

Status:<\/strong> \u2705 Accepted \u2014 awaiting presentation. The related manuscript has been accepted by Sexual Medicine<\/em> and is listed above under Peer-Reviewed Publications.<\/p>\n\n\n\n

Official Listing:<\/strong> Verified in the SCS AUA 2026 Official Program Schedule \u2197<\/a><\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n

\ud83d\udd2c POSTER PRESENTATION \u00b7 CO-AUTHOR \u00b7 NOW PUBLISHED<\/p>\n\n\n\n

Testosterone Replacement Therapy in Male Octogenarians: Clinical Outcomes and Adverse Event Rates \u2014 A Retrospective Cohort Study<\/h3>\n\n\n\n

Authors:<\/strong> Peyton Coady, Rishika Chidananda, Amelia Oppenheimer, Arnaav Walia, Beatriz Hernandez, David Hinojosa-Gonzalez, Soarawee Weerasopone, Vinayak Madhusoodanan, Taylor Kohn, Mohit Khera<\/p>\n\n\n\n

Affiliation:<\/strong> Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA<\/p>\n\n\n\n

Session:<\/strong> Male & Female Sexual & Reproductive Poster Session 1<\/p>\n\n\n\n

Presentation:<\/strong> Thursday, September 10, 2026 \u00b7 2:00 PM<\/p>\n\n\n\n

Role:<\/strong> Co-Author<\/p>\n\n\n\n

Status:<\/strong> \u2705 Accepted \u2014 awaiting presentation. This work is now published<\/strong> in The Journal of Sexual Medicine<\/em>, 23(9), qdag258, 22 August 2026 \u2014 see the Peer-Reviewed Publications section above for the findings and the full citation.<\/p>\n\n\n\n

Published Article:<\/strong> 10.1093\/jsxmed\/qdag258 \u2197<\/a><\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n

\ud83d\udccd 27th Annual Fall Scientific Meeting, Sexual Medicine Society of North America \u00b7 JW Marriott Orlando Grande Lakes, Orlando, Florida, USA \u00b7 October 8\u201311, 2026<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n

\ud83d\udd2c ACCEPTED ABSTRACT \u00b7 CO-AUTHOR<\/p>\n\n\n\n

Quantitative Ultrasound Mapping of Corporal Fibrosis: Early Validation of High-Frequency Imaging Against Histologic Collagen Content in Men Undergoing Penile Prosthesis Surgery<\/h3>\n\n\n\n

Abstract reference:<\/strong> #32519<\/p>\n\n\n\n

Affiliation:<\/strong> Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA<\/p>\n\n\n\n

Role:<\/strong> Co-Author (fifth author)<\/p>\n\n\n\n

Scope:<\/strong> An early validation study testing whether high-frequency ultrasound of the corpora cavernosa corresponds to histologic collagen content in tissue taken during penile prosthesis surgery \u2014 work aimed at assessing corporal fibrosis before an operation rather than discovering it during one.<\/p>\n\n\n\n

Status:<\/strong> \u2705 Accepted. Presentation format and session time are set by the SMSNA programme office and are not yet announced.<\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n

\ud83d\udd2c ACCEPTED ABSTRACT \u00b7 CO-AUTHOR<\/p>\n\n\n\n

Collagen-to-Muscle Ratio Correlates With Global and Stepwise Operative Difficulty During Inflatable Penile Prosthesis Surgery<\/h3>\n\n\n\n

Abstract reference:<\/strong> #31194<\/p>\n\n\n\n

Affiliation:<\/strong> Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA<\/p>\n\n\n\n

Role:<\/strong> Co-Author (fifth author)<\/p>\n\n\n\n

Scope:<\/strong> Corpus cavernosal tissue taken during inflatable penile prosthesis surgery was examined microscopically, and the collagen-to-muscle ratio was compared against how difficult the operation proved overall and at each individual step.<\/p>\n\n\n\n

Status:<\/strong> \u2705 Accepted. Presentation format and session time are set by the SMSNA programme office and are not yet announced.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n\n\n\n
\n

Research Focus Areas<\/h2>\n\n\n\n

Active research interests aligned with clinical practice in Men’s Health, Sexual Medicine, and Female Urology.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\n

\u2b50 Erectile Dysfunction in Aging Men<\/h3>\n\n\n\n

Clinical drivers, hormonal patterns, and treatment escalation strategies for first-presentation ED in elderly patients \u2014 including testosterone profiles and psychosocial factors.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

\u2b50 Vascular ED in Young Men<\/h3>\n\n\n\n

Hemodynamic evaluation of erectile dysfunction in men under 40, with focus on obesity, obstructive sleep apnea, and endothelial dysfunction as early markers of cardiovascular risk.<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\n

\u2b50 Testosterone Replacement Therapy<\/h3>\n\n\n\n

Evidence-based hypogonadism management \u2014 from diagnostic protocols to monitoring strategies, with attention to special populations including post-prostate cancer survivors.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

\u2b50 Female Urology & Incontinence<\/h3>\n\n\n\n

Validated quality-of-life instruments (IIQ-7, UDI-6) for Thai women with urinary incontinence \u2014 enabling reliable clinical assessment in the Thai-speaking population.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n\n\n\n
\n

Where the Research Happens<\/h2>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\"Dr.
Baylor Medicine at McNair Campus, Houston<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n
\"Dr.
Laboratory for Male Reproductive Research and Testing \u2014 Scott Department of Urology, Baylor College of Medicine<\/figcaption><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n\n\n\n
\n

Book a Consultation<\/h2>\n\n\n\n

Dr. Soarawee’s clinical practice is at Bangkok Hospital Headquarters, and he visits Samitivej Sriracha twice monthly. International patients are welcome \u2014 consultations available in English and Thai.<\/p>\n\n\n\n

Bangkok Hospital Telemedicine is available for patients who cannot attend in person, including international patients \u2014 arrange it in advance by email to the Urology department at bhquro@bdms.co.th<\/a>. Samitivej Sriracha is in-person only. Questions about cost are answered by the hospital rather than by Dr. Soarawee, using the same contacts.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Bangkok Hospital \u2014 Online Booking<\/a><\/div>\n\n\n\n
Samitivej Sriracha \u2014 Call 088-022-1445<\/a><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

This page is a record of academic work and is provided for information only. It is not medical advice and does not create a doctor\u2013patient relationship. Research findings describe groups of patients and do not tell you what is right for your own situation. Dr. Soarawee does not provide advice, diagnosis or prescriptions through personal messaging channels or social media, and does not operate any public social media account \u2014 any account offering private consultation in his name is fraudulent. In an emergency, attend the nearest emergency department or call 1669 in Thailand.<\/em><\/p>\n\n\n\n